Melanoma
Conference Coverage
Melanoma In Situ Diagnoses Ramping Up
Major Finding: Roughly 40% of invasive melanomas in a large prospectively followed population were diagnosed prior to age 60, compared with 20% of...
News
ASCO, SSO Back Sentinel Lymph Node Biopsy in Melanoma
News
FDA Warns of QT Prolongation with Ondansetron Dose
News
Eyeglasses May Offer Periocular AK Protection
Major Finding: Patients who didn’t regularly wear eyeglasses had a 40% higher rate of developing AKs on periocular skin.Data Source: A 4-year...
Conference Coverage
Scalp Cooling Protects Against Chemotherapy-Induced Alopecia
News
Vemurafenib's Efficacy in Melanoma Wanes Over Time
Major Finding: At a median follow-up of 9.5-12.5 months, vemurafenib conferred a 30% reduction in the risk of death vs.
News
Most Cancers Not Elevated in Vasculitis
Major Finding: Patients with circulating antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis had a 2.78-fold greater incidence of...
News
Aspirin Found to Protect Against Melanoma
Major Finding: Postmenopausal women who reported using aspirin regularly at baseline went on to have an 11%-30% reduction in the risk for...
News
Vismodegib Continues to Prove BCC Effectiveness
Major Finding: In the first trial, the response rate for vismodegib-treated patients was 30% for the metastatic group and 43% for the locally...
Conference Coverage
Stanford Experience Shows Long Metastatic BCC Survival
Major Finding: The median overall survival from the time of diagnosis of metastatic basal cell carcinoma was 7.8 years in a single-center series,...
Conference Coverage
Two Targeted Agents Best Chemotherapy in BRAF-Mutant Melanoma
Major Finding: Relative to chemotherapy, trametinib improved progression-free survival (hazard ratio, 0.45) and overall survival (HR, 0.54), and...